Revaccination of Non- and Low- Responders after a Standard Three Dose Hepatitis B Vaccine Schedule

Ke Han,Xiaoping Shao,Huizhen Zheng,Chenggang Wu,Jianqiong Zhu,Xiaoli Zheng,Yonghui Zhang

DOI: https://doi.org/10.4161/hv.21818

2012-01-01

Human Vaccines & Immunotherapeutics

Abstract:Background: Guangdong province of China is HBV high endemicity and 1.6 million neonates are administrated 5 mu g yeast recombinant anti-HBV vaccine each year. But few studies are performed to evaluate the immunogenicity and revaccination effect on non-and low-responders.Results: Of 1,814 subjects, 3.1% were non-responders (anti-HBs titer < 10 mIUml(-1)) and 28.9% were low-responders (anti-HBs >= 10 mIUml(-1) and < 100 mIUml(-1)). Low birth weight (LBW) was a risk factor for non- and low-responders (RR = 1.6, 95% CI = 1.2-2.0). After revaccination, of the 34 non-responders, 14.7% became low-responders and 85.3% became responders. Of the 74 low-responders, 21.6% remained at the same level and 78.4% shifted into responder category.Methods: A total of 2,199 children were administered intramuscularly with 5 mu g vaccine at 0, 1 and 6 mo after birth. A 3 ml blood sample was drawn from each infant 1 mo after the third dose for determination of anti-HBs level. Three additional doses (10 mu g each) were given to non-and low-responders.Conclusions: Based on the lower responding rate after the primary immunization cycle and the higher responding rate after the additional cycle, measurement of anti-HBs level should be considered for people who had been immunized with three-dose 5 mu g HB vaccine in Guangdong, especially for specific populations including LBW infants, healthcare workers, and patients with immunodeficiency disorders. An amount of 10 mu g vaccine should be revaccinated to any non- and low-responders to provide adequate seroprotection.